Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

I-SENS: Emerging As A Total Diabetes Solutions Company


We maintain BUY on i-SENS in light of the momentum to come from its transformation into a total diabetes solution company.

Earnings in the US and Europe continue to grow and the Chinese unit is normalizing.

We raise our target price from KRW31,000 to KRW35,000.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.